CrowdOut will focus on airway re-hydration and clearance of mucus for those suffering from Cystic Fibrosis by boosting the activity of THEM16A.  

By targeting small molecule activations for TMEM16A using HTS based screening and our existing assemblage of small molecule libraries we plan to nominate a TMEM16A candidate and start our clinical studies within the next 5 years.